EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe
EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operations in Germany. Amneal Deutschland already distributes several EVER Pharma products in Germany and is a strongly established player in the German hospital market. The acquired entity will be rebranded to EVER Pharma GmbH.
“This acquisition represents another milestone in the expansion of EVER Pharma’s commercial footprint in Europe. With this new operation, EVER Pharma extends its portfolio in Germany and establishes a solid platform for the growth of its portfolio and pipeline” commented Georges Kahwati, General Manager of EVER Pharma.
“We are pleased to establish another EVER affiliate in one of the key European markets in line with our strategy of establishing our own business presence in core markets.” added Julia Hillebrand, Managing Director and Owner.
About EVER Pharma:
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialization of products in the areas of neurology, critical care, anesthesia and oncology. EVER Pharma markets in over 70 countries through wholly owned affiliates and distribution partners.
To learn more about this acquisition:
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-VERIMATRIX21.2.2020 17:37:04 CET | Press release
Verimatrix and Qt Company Join Forces at Embedded World 2020 to Showcase IoT Shielding
COUNTERPOINT-RESEARCH21.2.2020 15:02:10 CET | Press release
Counterpoint Research: Fugro, PTC and Mapbox Lead the Spatial Intelligence Platform Capabilities
PHILIP-MORRIS-INTL21.2.2020 15:00:09 CET | Press release
Prohibition at Any Cost? Philip Morris International Hits Back at Global Campaign of Disinformation
NY-SIMPSON-THACHER/RUPAL21.2.2020 11:02:10 CET | Press release
Preeminent Tax Practitioner Yash Rupal to Join Simpson Thacher in London
TEJ-KOHLI-FOUNDATION21.2.2020 09:02:12 CET | Press release
Tej Kohli Foundation Seeks to Incubate New Projects That Can Eliminate Corneal Blindness By 2035
CA-ADVANCED-BIONICS21.2.2020 03:25:10 CET | Press release
Advanced Bionics Announces Voluntary Field Corrective Action of The HiRes Ultra / Ultra 3D Cochlear Implant
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom